Evolution of human IL4I1 preference for aromatic amino acids from a broad-specificity L-amino acid oxidase ancestor.

Authors

Marta Massari, Jonatan Caroli, Marco Malatesta, Sara Marchese, Filip Sente, Letizia Pizzorni, Andrea Mattevi

Published in

Proceedings of the National Academy of Sciences of the United States of America. Volume 123. Issue 33. Pages e2608436123. Aug 18, 2026. Epub Aug 12, 2026.

Abstract

IL4I1, a human L-amino acid oxidase (LAAO), has drawn considerable interest for its role in catabolism with implications for cancer biology and immune modulation. The function and activity of this enzyme in humans contrast with the cytotoxic effects exerted by LAAOs from snake venoms. The inherent instability of IL4I1 has hindered detailed biochemical characterization and its exploration as a drug target. In this study, we present a comprehensive biochemical and structural investigation of tetrapod LAAOs, with a focus on human IL4I1 and its evolutionary relationship to venomous snake proteins. By exploiting ancestral sequence reconstruction, we inferred, expressed, and characterized the tetrapodal ancestral LAAO and mammalian ancestral IL4I1 and compared their properties to recombinant human IL4I1 purified from human cells. The tetrapodal ancestor displays a broad substrate profile, acting on hydrophobic, polar, and positively charged amino acids, whereas human IL4I1 prefers aromatic amino acids. Guided by crystal structures, we engineered eight ancestral protein variants to mimic mammalian- and snake-like active site configurations. Kinetic analyses of these variants reveal distinct evolutionary trajectories: one leading to the high-activity venomous LAAOs of reptiles, and another to the aromatic-selective IL4I1 of mammals. Overall, our findings demonstrate that the functional divergence between human IL4I1 and venomous snake LAAOs is underpinned by evolutionary shifts in substrate specificity and catalytic efficiency.

PMID:
42585003
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.